The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab
Several Bevacizumab products are approved for clinical use, with many others in late-stage clinical development worldwide. To aid the harmonization of potency assessment across different Bevacizumab products, the first World Health Organization (WHO) International Standard (IS) for Bevacizumab has b...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2021-10-01
|
| Collection: | Biomolecules |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2218-273X/11/11/1610 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|